Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

2026 Revised Recommendations of The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.

BACKGROUND Diagnosis, staging, and treatment of early-stage lung cancer remains an important area of thoracic surgical oncology. The previous AATS expert consensus document, published in 2023, reflected critical recommendations for the workup and management of this disease, including the adoption of chemoimmunotherapy...

B. Kidane, M. Bott, Jonathan D. Spicer et al. · 0 citations
Open access Sep 2026

Neoadjuvant Chemoradiotherapy Versus Perioperative Chemotherapy ± Immunotherapy in Resectable Esophageal Adenocarcinoma.

OBJECTIVE We sought to compare pathologic responses, perioperative outcomes, and early survival between induction chemoradiotherapy and perioperative chemotherapy ± immunotherapy in patients with resectable esophageal adenocarcinoma. METHODS Using our prospectively maintained institutional database, we retrospectivel...

Aroub Alkaaki, Nian-Ye Zheng, N. Toumbacaris et al. · 0 citations
Open access Sep 2026

Senescence-directed nanotherapy ameliorates fibrosis and overcomes immune exclusion in cancer

It is shown that P-selectin is expressed by a subset of senescent-like cells in fibrotic tissues and tumors, which establishes SMNPs as a generalizable strategy to target pathogenic senescent cell subsets across fibrosis and cancer.

Clemens Hinterleitner, Valentin J. A. Barthet, Hailey V. Goldberg et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.